| 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on … Writing Committee Members, CM Otto, RA Nishimura, RO Bonow, ... Journal of the American College of Cardiology 77 (4), e25-e197, 2021 | 4863* | 2021 |
| 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice … PA Heidenreich, B Bozkurt, D Aguilar, LA Allen, JJ Byun, MM Colvin, ... Journal of the American College of Cardiology 79 (17), e263-e421, 2022 | 4386* | 2022 |
| Diuretic strategies in patients with acute decompensated heart failure GM Felker, KL Lee, DA Bull, MM Redfield, LW Stevenson, SR Goldsmith, ... New England Journal of Medicine 364 (9), 797-805, 2011 | 1833 | 2011 |
| 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association … SR Ommen, S Mital, MA Burke, SM Day, A Deswal, P Elliott, LL Evanovich, ... Journal of the American College of Cardiology 76 (25), e159-e240, 2020 | 1649* | 2020 |
| Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST) A Deswal, NJ Petersen, AM Feldman, JB Young, BG White, DL Mann Circulation 103 (16), 2055-2059, 2001 | 1452 | 2001 |
| 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint … Writing Committee Members, M Gulati, PD Levy, D Mukherjee, ... Journal of the American College of Cardiology 78 (22), e187-e285, 2021 | 1359 | 2021 |
| Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial MM Redfield, HH Chen, BA Borlaug, MJ Semigran, KL Lee, G Lewis, ... Jama 309 (12), 1268-1277, 2013 | 1307 | 2013 |
| Ultrafiltration in decompensated heart failure with cardiorenal syndrome BA Bart, SR Goldsmith, KL Lee, MM Givertz, CM O'Connor, DA Bull, ... New England Journal of Medicine 367 (24), 2296-2304, 2012 | 1106 | 2012 |
| Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction S Ather, W Chan, B Bozkurt, D Aguilar, K Ramasubbu, AA Zachariah, ... Journal of the American College of Cardiology 59 (11), 998-1005, 2012 | 807 | 2012 |
| Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association B Bozkurt, M Colvin, J Cook, LT Cooper, A Deswal, GC Fonarow, ... Circulation 134 (23), e579-e646, 2016 | 698 | 2016 |
| Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not … SM Dunlay, MM Givertz, D Aguilar, LA Allen, M Chan, AS Desai, A Deswal, ... Circulation 140 (7), e294-e324, 2019 | 543 | 2019 |
| Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial HH Chen, KJ Anstrom, MM Givertz, LW Stevenson, MJ Semigran, ... Jama 310 (23), 2533-2543, 2013 | 511 | 2013 |
| Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure A Deswal, B Bozkurt, Y Seta, S Parilti-Eiswirth, FA Hayes, C Blosch, ... Circulation 99 (25), 3224-3226, 1999 | 497 | 1999 |
| Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific … B Bozkurt, D Aguilar, A Deswal, SB Dunbar, GS Francis, T Horwich, ... Circulation 134 (23), e535-e578, 2016 | 417 | 2016 |
| Obesity and cardiovascular disease: a risk factor or a risk marker? T Mandviwala, U Khalid, A Deswal Current atherosclerosis reports 18, 1-10, 2016 | 346 | 2016 |
| Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study MM Givertz, KJ Anstrom, MM Redfield, A Deswal, H Haddad, J Butler, ... Circulation 131 (20), 1763-1771, 2015 | 322 | 2015 |
| Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment N Palaskas, J Lopez‐Mattei, JB Durand, C Iliescu, A Deswal Journal of the American Heart Association 9 (2), e013757, 2020 | 318 | 2020 |
| Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria WD Rosamond, PP Chang, C Baggett, A Johnson, AG Bertoni, E Shahar, ... Circulation: Heart Failure 5 (2), 152-159, 2012 | 317 | 2012 |
| Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference AA House, C Wanner, MJ Sarnak, IL Piña, CW McIntyre, P Komenda, ... Kidney international 95 (6), 1304-1317, 2019 | 315 | 2019 |
| Transitions of care in heart failure: a scientific statement from the American Heart Association NM Albert, S Barnason, A Deswal, A Hernandez, R Kociol, E Lee, S Paul, ... Circulation: Heart Failure 8 (2), 384-409, 2015 | 287 | 2015 |
Biykem BozkurtProfessor of Medicine, Baylor College of MedicineVerified email at bcm.edu
